Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721

Excerpt

To the Editor: The past decade has witnessed the introduction of numerous novel therapeutic agents for type 2 diabetes, from thiazolidinediones to engineered insulins, not to mention the incretin-based therapeutics that are on the verge of entering the market. Confronted with so many options, many physicians could feel confused and unsure regarding the choice of therapeutic agent. It may therefore be understandable that the American Diabetes Association and the European Association for the Study of Diabetes have judged it necessary to generate a consensus statement on the subject, presented simultaneously in Diabetologia and Diabetes Care by Nathan et al. [1, 2]. Nevertheless, I regret that these two societies, which together exert the strongest influence on world diabetes opinion, decided to publish a consensus algorithm, because I believe that diabetes treatment is too complex to be reduced to a useful algorithm. …